FDA Announces Recipients of Priority Drug Review Vouchers
The FDA has announced the first nine recipients of priority review vouchers, which provide expedited drug review for products aligned with national health priorities.
The program aims to support companies with products that address the agency's national health priorities, offering a faster review process.
President Trump highlighted one of the recipients, EMD Serono, at a White House news conference on expanding access to in vitro fertilization.
- EMD Serono received a voucher for Pergoveris, a drug that stimulates egg development and has already been approved in 74 countries.
- The company agreed to lower the prices of its existing fertility drugs in exchange for the voucher.
To read the full list of recipients and more information, subscribe to STAT+.
Author's summary: FDA announces first recipients of priority review vouchers.
More News
- Military archbishop: Army’s cancellation of religious support contracts unfairly harms Catholics - OSV News
- Belvidere North Edges Hononegah 27-24, in Thriller as Community Rallies for Benny
- Red-hot B.C. Lions win 5th straight, dumping Edmonton Elks 37-24
- Tijuana Xolos road struggles continue with 4-3 loss to Puebla - East Village Times
- The Rockford Symphony Orchestra spent an evening at Hononegah High School
- Tenant protection ordinances don’t work | The Alpine Sun